Drug Landscape ›
QUINESTROL ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 10
Most-reported reactions
Acute Hepatic Failure — 1 report (10%) Anger — 1 report (10%) Blood Cholesterol Increased — 1 report (10%) Breast Cancer Female — 1 report (10%) Chronic Obstructive Pulmonary Disease — 1 report (10%) Depressed Mood — 1 report (10%) Depression — 1 report (10%) Drug Ineffective — 1 report (10%) Drug-Induced Liver Injury — 1 report (10%) Injection Site Erythema — 1 report (10%)
Source database →
QUINESTROL in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is QUINESTROL approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for QUINESTROL in United States?
Marketing authorisation holder not available in our data.